These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29513153)

  • 1. Biomarkers identify the Binswanger type of vascular cognitive impairment.
    Barry Erhardt E; Pesko JC; Prestopnik J; Thompson J; Caprihan A; Rosenberg GA
    J Cereb Blood Flow Metab; 2019 Aug; 39(8):1602-1612. PubMed ID: 29513153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binswanger's disease: biomarkers in the inflammatory form of vascular cognitive impairment and dementia.
    Rosenberg GA
    J Neurochem; 2018 Mar; 144(5):634-643. PubMed ID: 28902409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials.
    Rosenberg GA; Prestopnik J; Adair JC; Huisa BN; Knoefel J; Caprihan A; Gasparovic C; Thompson J; Erhardt EB; Schrader R
    J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1324-30. PubMed ID: 25618903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.
    Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Jagust WJ; Chui HC; Kramer JH; Reed BR; Miller BL; Yaffe K; Weiner MW
    Neurology; 2003 Aug; 61(3):358-64. PubMed ID: 12913198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier permeability abnormalities in vascular cognitive impairment.
    Taheri S; Gasparovic C; Huisa BN; Adair JC; Edmonds E; Prestopnik J; Grossetete M; Shah NJ; Wills J; Qualls C; Rosenberg GA
    Stroke; 2011 Aug; 42(8):2158-63. PubMed ID: 21719768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus statement for diagnosis of subcortical small vessel disease.
    Rosenberg GA; Wallin A; Wardlaw JM; Markus HS; Montaner J; Wolfson L; Iadecola C; Zlokovic BV; Joutel A; Dichgans M; Duering M; Schmidt R; Korczyn AD; Grinberg LT; Chui HC; Hachinski V
    J Cereb Blood Flow Metab; 2016 Jan; 36(1):6-25. PubMed ID: 26198175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment.
    Gasparovic C; Prestopnik J; Thompson J; Taheri S; Huisa B; Schrader R; Adair JC; Rosenberg GA
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):715-21. PubMed ID: 23418212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased blood-brain barrier permeability in white matter lesions of Binswanger's disease evaluated by contrast-enhanced MRI.
    Hanyu H; Asano T; Tanaka Y; Iwamoto T; Takasaki M; Abe K
    Dement Geriatr Cogn Disord; 2002; 14(1):1-6. PubMed ID: 12053125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
    Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
    Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T; Shiino A; Akiguchi I
    Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study.
    Jokinen H; Kalska H; Ylikoski R; Madureira S; Verdelho A; Gouw A; Scheltens P; Barkhof F; Visser MC; Fazekas F; Schmidt R; O'Brien J; Hennerici M; Baezner H; Waldemar G; Wallin A; Chabriat H; Pantoni L; Inzitari D; Erkinjuntti T;
    Cerebrovasc Dis; 2009; 27(4):336-44. PubMed ID: 19218799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binswanger's disease: toward a diagnosis agreement and therapeutic approach.
    Huisa BN; Rosenberg GA
    Expert Rev Neurother; 2014 Oct; 14(10):1203-13. PubMed ID: 25201523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus.
    Du AT; Schuff N; Laakso MP; Zhu XP; Jagust WJ; Yaffe K; Kramer JH; Miller BL; Reed BR; Norman D; Chui HC; Weiner MW
    Neurology; 2002 Jun; 58(11):1635-41. PubMed ID: 12058091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of MRI-defined subcortical vascular disease.
    Pohjasvaara T; Mäntylä R; Ylikoski R; Kaste M; Erkinjuntti T
    Alzheimer Dis Assoc Disord; 2003; 17(4):236-42. PubMed ID: 14657788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.
    Fein G; Di Sclafani V; Tanabe J; Cardenas V; Weiner MW; Jagust WJ; Reed BR; Norman D; Schuff N; Kusdra L; Greenfield T; Chui H
    Neurology; 2000 Dec; 55(11):1626-35. PubMed ID: 11113215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcortical gray matter N-acetylaspartate reduction in two cases of vascular dementia.
    Ben Salem D; Walker PM; Osseby GV; Krausé D; Giroud M; Brunotte F
    Clin Imaging; 2003; 27(1):14-7. PubMed ID: 12504314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and white matter damage in vascular cognitive impairment.
    Rosenberg GA
    Stroke; 2009 Mar; 40(3 Suppl):S20-3. PubMed ID: 19064797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy.
    Capizzano AA; Schuff N; Amend DL; Tanabe JL; Norman D; Maudsley AA; Jagust W; Chui HC; Fein G; Segal MR; Weiner MW
    AJNR Am J Neuroradiol; 2000 Apr; 21(4):621-30. PubMed ID: 10782769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.